Copy
December 2021

SMICS 2020-2021 Annual Report

MPCCC Year in Review

2021 has been a progressive year for the MPCCC, despite the challenges of social isolation and rapidly changing circumstances for our healthcare providers and patients.

Researchers Develop a World-First Antibody-Drug Delivery System

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek out diseased cells with the highest precision, resulting in fewer adverse effects for the patient.

Continue reading »

Monash Scientists Expose Tumour-Causing Protein

Monash University scientists have discovered the structure of the protein behind neurofibromatosis type 1 (NF1), a common genetic condition that causes tumours to form on nerve tissue.

Continue reading »

Launch of Peninsula Health’s Cancer and Clinical Trials Hub at Rosebud

Federal funding and partnerships with The Alfred and Cabrini Health will improve access to cancer clinical trials in outer metro and regional Victoria.

Continue reading »

Cancer Trial Gives New Hope to Australian Patients

An international study looking at whether high and very tightly controlled doses of radiation can cure cancers previously considered incurable is in progress at The Alfred, with the first patient completing treatment in the trial.

Continue reading »

Lifting the Bar in Radiation Therapy

All cancer patients at The Alfred receiving external beam radiation treatment will now have access to state-of-the-art technology, thanks to the introduction of a new $3.15 million Linear Accelerator (LINAC).

Continue reading »

Alfred Health SURC Wins Runner-up in the Chair of the Board Awards

Congratulations to the team at Alfred Health for being awarded runner-up in the Chair of the Board Awards for their entry 'Alfred Cancer - Implementation of Symptom and Urgent Review Clinics'

Continue reading »

ASPIRE Award to Support Blood Cancer Research

Monash University’s Associate Professor Ross Dickins has been awarded a USD $232,000 (approximately $325,000 AUD) ASPIRE Award to support his research into preventing relapse following acute myeloid leukemia (AML) therapy from US-based philanthropic organisation The Mark Foundation for Cancer Research.

Continue reading »

Cancer in Victoria 2020

The Victorian Cancer Registry has released the 2020 Annual Statistics & Trends report. Read the report »

Help Your Patients Get Factsinated

You can direct people affected by cancer to the frequently asked questions on the Cancer Council Victoria website, which explain the increased risk of COVID-19 for people with cancer, addresses vaccine misinformation and encourages people to contact our cancer nurses on 13 11 20 for information and support. Get the facts on all things cancer and COVID-19 »

Exercise and Cancer | Cancer Council NSW

Research shows that exercise has many benefits both during and after cancer treatment. It can help with side effects, speed up recovery, and improve quality of life. The Cancer Exercise Toolkit is a resource to support clinicians delivering cancer rehabilitation. Find out more »

In addition, an overview about the development of the Cancer Exercise Toolkit, including the co-design process was presented at a recent webinar, and can be accessed here  »

Breast Cancer Network: Information for Health Professionals

The BCNA website is helping health professionals to quickly find the resources and information needed to support people affected by breast cancer.

Find out more »

National Pancreatic Cancer Roadmap

Cancer Australia’s National Pancreatic Cancer Roadmap will identify key priority areas for action over the next five years to improve outcomes for people with pancreatic cancer. Read the latest update on the development of the National Pancreatic Cancer Roadmap here »

Pancreatic Cancer Resectability Project Update

A twelve-month pilot to test a new radiological synoptic reporting tool at Alfred and Austin Hospitals has now concluded.

Find out more »

The CanEAT Pathway: Nutrition and Cancer: Are You Looking for Answers?

A suite of new credible and interactive resources, co-designed by people with cancer, carers and health professionals to achieve and deliver optimal cancer nutrition care and fill evidence-based gaps in cancer nutrition information.

Access the resources »

CAREER OPPORTUNITIES

MPCCC Communications Manager

An exciting opportunity has become available for a part-time Communications Manager to join the Monash Partners Comprehensive Cancer Consortium (MPCCC). You will work alongside the MPCCC Chief Executive, and MPCCC Chief Operating Officer to play a key role in delivering MPCCC’s strategic priorities through the development and implementation of its Communication and Public Relations Plan.

More information and to apply »

VCCC Alliance - Seeking MPCCC Co-Chair for Penile and Testicular Cancer Forum

The VCCC Alliance is seeking expressions of interest from amongst the MPCCC clinical community to co-Chair a regular, ongoing, state-wide penile and testicular cancer forum for clinicians and researchers with an interest and expertise in these areas. 

Applications will close on 21 December. To express your interest in this opportunity or if have any questions, please contact: Jessica Freeman: Jessica.freeman@unimelb.edu.au

More information »

FUNDING OPPORTUNITIES

Cancer Australia - Supporting people with Cancer (SPWC) Grant initiative

The SPWC Grant initiative will fund evidence-based projects to reduce the impact of cancer and better support people affected by cancer. Community organisations and Aboriginal and Torres Strait Islander organisations supporting people affected by cancer can apply for grants of up to $120,000 (GST exclusive) over a three-year period (2022-2025). Grants for projects to be conducted over a period less than 3 years should not exceed $40,000 (GST exclusive) per annum.

Applications Close 7-Feb-2022 2:00 pm (ACT Local Time)
For all information and to apply

More information and to apply »

MRFF - Genomics Health Futures Mission 2021 Grant Opportunity

Closes 16 Feb 2022 (Min Data 02 Feb)

Stream 1 (Targeted Call for Research): develop disease-agnostic, high throughput and scalable functional genomics platforms to increase the diagnostic rate of unresolved cases and accelerate the development of experimental therapeutics
Maximum grant value is $3 million. Total Grant pool $20M
Grants up to 5 years

Stream 2 (Targeted Call for Research): develop new models of genomic newborn screening.
Maximum grant value is $3 million. Total Grant pool $12M
Grants up to 5 years

Stream 3 (Targeted Call for Research): through a competitively selected national consortium, conduct research addressing emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets.
Maximum grant value is $5 million.Total Grant pool $5M  
Grants up to 5 years

Stream 4 (Targeted Call for Research): through a competitively selected national consortium, conduct research to develop effective approaches for responsible, culturally appropriate and nationally consistent involvement of Aboriginal and/or Torres Strait Islander people in genomics research and clinical practice
Maximum grant value is $5 million.Total Grant pool $5M  
Grants up to 5 years

Stream 5 (Targeted Call for Research): through a competitively selected national consortium, conduct research to enrich genomics databases to support the inclusion of culturally and linguistically diverse groups in genomics research, and equitable benefit from genomics in health
Maximum grant value is $10 million.Total Grant pool $10M  
Grants up to 5 years

Stream 6 (Incubator): conduct small-scale development projects to establish feasible, evidence-based approaches for population cohort research, focusing on culturally and linguistically diverse groups, including:
Maximum grant value is $1 million.Total Grant pool $4M  
Grants up to 2 years

More information and to apply »

MRFF - 2021 Stem Cell Therapies Grant Opportunity

Stream 1 (Accelerator): developing novel stem cell-based therapies that have the potential to transform clinical care (see guidelines for full details)
Grants up to $7M for up to 5 years

Stream 2 (Accelerator): evaluating and performing pre-clinical screening of new therapeutics using human tissues made from stem cells. (see guidelines for full details)
Grants up to $5M for up to 5 years

Closing date 23 February 2022

More information »

MRFF - 2021 Dementia, Ageing and Aged Care Grant Opportunity

Stream 1 (Accelerator): identifying and implementing interventions to extend healthy, active years of life.

Stream 2 (Targeted Call for Research): implementing appropriate support approaches that reduce stigma associated with dementia and enable better outcomes for older people, including those in vulnerable populations.

Stream 3 (Targeted Call for Research): improving the consistency and quality of care for older Australians across all care settings

Stream 4 (Incubator): supporting the development of more effective, evidence-based care approaches using data for older Australians in care.

Minimum data: 02 February 2022 Closing date 16 February 2022  

More information »

 

HAVE YOUR SAY

The Australian Cancer Plan 2023-2033

Cancer Australia is developing the Australian Cancer Plan: a 10-year plan for national action, with 2-, 5- and 10-year priorities and goals. 

Public Consultation for the Australian Cancer Plan is now open. Cancer Australia invites you to share your vision for the Australian Cancer Plan. We are keen to hear ambitious and transformational ideas – so be bold and think big. You can answer questions in a short survey or upload a submission. The survey will remain open until 18 February 2022.

Find out more and complete the survey »

Optimal Care Pathway (OCP) for Adolescents and Young Adults (AYA) with Cancer

Health professionals, health services, people affected by cancer and other interested stakeholders are invited to provide input to the draft Optimal Care Pathway for Adolescents and Young Adults with Cancer. The draft will be open for consultation until Sunday 19 December

Access the document »

Good Clinical Practice Courses in 2022
From February 2022, Monash Partners will offer monthly Refresher Good Clinical Practice (GCP) training for all staff involved in pharma or interventional clinical research who have previously completed training. Introduction to Good Clinical Practice will resume in 2022.
More information »

2nd Supportive Care Showcase: Innovative Ideas and New Realities
When: Thursday 24 February
Where: Online
More information/register »

Resilience Revolution Community of Practice Program
When: January 2022 – December 2023
More information/register »
 

 

4th Victorian Cancer Survivorship Conference -  Shifting Gears, Rethinking Survivorship
Rethinking Survivorship will consider how recent advances in cancer survivorship research and care can be adopted, as well as consider future system transformation, to better meet the needs of the growing survivorship population. We will particularly recognise changes as a result of the COVID-19 pandemic.

When: 24 - 25 March 2022
Where: Bayview Eden Hotel, Melbourne
More information »

CNSA 24TH Annual Conference: Cancer Nursing Workforce: Strong, Skilled and Specialised
When: 16 - 18 June
Where: Brisbane Convention & Exhibition Centre
Abstracts close 1 February 2022
More information/register  »

 

MPCCC Precision Oncology Seminars are recorded and available to watch on YouTube at any time. Catch up on presentations from Professor Melissa Southey, Professor Tony Purcell, Associate Professor Joseph Rosenbluh and more. Watch now »
 

Metformin rescues muscle function in BAG3 myofibrillar myopathy models Read article »

Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification Read article »

TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma Read article »
 

Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
Twitter
LinkedIn
If you would like to contribute to the MPCCC e-Newsletter email info@monashpartnersccc.org
Copyright © 2021 MPCCC, All rights reserved.